ArticleJournal of medicinal chemistry2022

BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor.

Daniel Meibom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.